Crossmark

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

Crossref DOI link: https://doi.org/10.1186/S12885-020-6688-8

Published: 2020-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Lee, Yong Jae

Kim, Hyun-Soo

Rim, John Hoon

Lee, Jung-Yun

Nam, Eun Ji

Kim, Sang Wun

Kim, Sunghoon

Kim, Young Tae
License Information

Text and Data Mining valid from 2020-03-04
More Information

Article History

Received: 10 November 2019

Accepted: 27 February 2020

First Online: 4 March 2020

Ethics approval and consent to participate

: The need for an approval was waived by the ‘Institutional Review Board of Severance Hospital at Yonsei University College of Medicine’ as the study was retrospective and individual patients were not identifiable.

: Not applicable.

: The authors declare that they have no conflicts of interest.